News Immunovia AB

Equities

IMMNOV

SE0006091997

Delayed Nasdaq Stockholm Other stock markets 09:27:44 2024-04-25 am EDT			5-day change	1st Jan Change
1.966 ^SEK	-6.38%		+11.41%	+12.42%

Apr. 22	Immunovia AB Announces Positive Results from the Model-Development Study for Its Next-Generation Pancreatic Cancer Detection Test	CI
Apr. 09	Immunovia, Proteomedix Create Assays for Pancreatic Cancer Detection Test	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Invitation to Immunovia's Q1 presentation	Apr. 23	AQ
Immunovia announces updated financial calendar	Apr. 22	AQ
Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test	Apr. 22	AQ
Immunovia AB Announces Positive Results from the Model-Development Study for Its Next-Generation Pancreatic Cancer Detection Test	Apr. 22	CI
Immunovia, Proteomedix Create Assays for Pancreatic Cancer Detection Test	Apr. 09	MT
Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study	Apr. 09	AQ
Immunovia Successfully Develops Assays to Measure Targeted Proteomedix for Its Next-Generation Pancreatic Cancer Test - Moving Forward Towards Model-Development Study	Apr. 09	CI
Immunovia announces updated financial calendar	Mar. 12	AQ
Transcript : Immunovia AB, 2023 Earnings Call, Feb 21, 2024	Feb. 21
Immunovia Publishes Full Year Report for 2023	Feb. 21	AQ
Immunovia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21	CI
Immunovia AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
Invitation to Immunovia's Q4 presentation	Feb. 14	AQ
Immunovia appoints Norma Alonzo Palma as new Vice President of Clinical and Medical Affairs	Jan. 31	AQ
Immunovia announces financial calendar for financial year 2024	Jan. 04	AQ
Immunovia AB Elects Melissa Farina and Valerie Bogdan-Powers as New Board Members	Nov. 21	CI
Bulletin from the extraordinary general meeting in Immunovia AB	Nov. 21	AQ
Transcript : Immunovia AB, Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Immunovia Publishes Interim Report for January-September 2023	Nov. 09	AQ
Immunovia AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Immunovia AB

Equities

IMMNOV

SE0006091997

Summary

Filters